Pharma News

Pharma Courses 
PAGE Admission

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Cluster Development Programme for Pharma Sector (CDS-PS) is launched by Government to provide support to the Pharmaceutical industry in becoming more capable, productive and competitive. End of this financial year, 06 Pharma Clusters are likely to come up of which 03 will be greenfields.

    [adsense:336x280:8701650588]

  • Sun Pharma Advanced Research Company Ltd. (SPARC) has licensed out glaucoma medicine Xelpros (latanoprost BAK-free eye drops) to a subsidiary of Sun Pharma for the US market.

  • Cervical cancer is the fourth commonest cause of cancer among women, and tragically is often diagnosed too late. Cervical cancer is a type of cancer that develops in a woman's cervix (the entrance to the womb from the vagina). It is caused by the human papillomavirus (HPV) which is easily spread by sexual intercourse. Cervarix is a vaccine against certain types of cancer-causing human papillomavirus (HPV). Currently, Cervarix, which with another vaccine, Gardasil, is being rolled out to shield young people from HPV. A new study has found that a single vaccine shot, rather than the recommended triple dose, may be enough to protect women against cervical cancer.  The new research is published in the The Lancet Oncology.

  • Glenmark Pharmaceuticals Inc., USA (Glenmark) get final approval by the United States Food & Drug Administration (FDA) for calcipotriene cream, 0.005 per cent, the therapeutic equivalent of Dovonex cream, 0.005 per cent of Leo Pharma A/S.  Glenmark strategy to start to shipping of calcipotriene cream, 0.005 per cent immediately.

  • A new research claims, Autism Spectrum Disorder More Frequently Observed in Boys Than in Girls. The study was published in the journal Molecular Autism.

    Autism spectrum disorder (ASD) is a condition that affects social interaction, communication, interests and behaviour. The study followed a large sample of boys and girls at high-risk for the disorder and other children at low risk beginning before 18 months of age. One in four high-risk boys were identified with the disorder at three years, compared to one in 10 high-risk girls.

  • Finnish researchers have developed the world's first paper-based drug test that enables a rapid analysis of whether a compound, such as morphine, is present in a given sample. Researchers from VTT Technical Research Centre of Finland used antibodies - produced by methods of molecular biology - as morphine sensing molecules to create the drug test printed on paper.

  • The immune system release specific antibodies when it encounters a virus. It can continue to produce those antibodies decades after an infection subsides. VirScan test detects those antibodies and uses them as a window in time to create a blueprint of nearly every virus an individual has encountered.  The test, known as VirScan, works by screening the blood for antibodies against any of the 206 species of viruses known to infect humans.Researchers at Columbia University found a DNA-based blood test which can determine a person's entire viral history. This new test can lead to early detection of hepatitis C, certain autoimmune diseases and cancers. This new innovation test only for a single suspected virus. The study appears in Science.

  • Under “Make in India” initiative India and the Netherlands have signed a Memorandum of Understanding  for the development of vaccines. The MoU was signed between visiting Prime Minister of Netherlands Mark Rutte and government of India in New Delhi. This cooperation between the two countries in the vaccine manufacturing segment is expected to result in large scale production of measles-rubella and other needed vaccine in the country. The ‘Make in India’ is a critical initiative for promoting access to health technology beyond the borders of India.

Subscribe to Pharma News